Effect of skin pain patches on pain medications requirement after surgery

Effect of preoperative application of buprenorphine transdermal patch on analgesic requirement in postoperative period in patients undergoing minimally invasive spine surgeries. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065277

Enrollment

Registered

2024-04-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Pain: Comparison of pain and haemodynamics before and after surgery Intervention2: Transdermal Buprenorphine patch: 10 mg transdermal buprenorphine patch will be applied 8 hours before

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade 1-2 Elective minimal invasive surgery

Exclusion criteria

Exclusion criteria: Pregnant women ASA grade 3-4 Emergency surgery Skin allergy Opioid dependance antidepressant drugs

Design outcomes

Primary

Measure	Time frame
IV Rescue analgesic diclofenac doseTimepoint: at the end of surgery. Postop 6,12, 18, 24, 36, 48, hrs	—

Secondary

Measure	Time frame
Haemodynamics visual analogue scale Ramsay sedation score adverse effects Timepoint: Intraoperative, at the end of surgery. Postop 6,12, 18, 24, 36, 48, hrs	—

Countries

India

Contacts

Public ContactSingam Geetha

Nizams Institute of Medical Sciences Hyyderabad: Pincode: 500082

singamgeetha11@gmail.com09441043075

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026